A detailed history of Ubs Group Ag transactions in Iradimed Corp stock. As of the latest transaction made, Ubs Group Ag holds 5,988 shares of IRMD stock, worth $327,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,988
Previous 4,728 26.65%
Holding current value
$327,244
Previous $207,000 45.41%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$43.23 - $50.29 $54,469 - $63,365
1,260 Added 26.65%
5,988 $301,000
Q2 2024

Aug 13, 2024

SELL
$40.36 - $44.7 $151,228 - $167,490
-3,747 Reduced 44.21%
4,728 $207,000
Q1 2024

May 13, 2024

BUY
$41.17 - $47.29 $50,927 - $58,497
1,237 Added 17.09%
8,475 $372,000
Q4 2023

Feb 09, 2024

BUY
$37.31 - $47.47 $162,261 - $206,447
4,349 Added 150.54%
7,238 $343,000
Q3 2023

Nov 09, 2023

SELL
$43.28 - $50.3 $525,808 - $611,094
-12,149 Reduced 80.79%
2,889 $128,000
Q2 2023

Aug 11, 2023

BUY
$38.88 - $50.61 $286,545 - $372,995
7,370 Added 96.11%
15,038 $717,000
Q1 2023

May 12, 2023

SELL
$28.48 - $42.14 $64,023 - $94,730
-2,248 Reduced 22.67%
7,668 $301,000
Q4 2022

Feb 08, 2023

BUY
$26.9 - $30.58 $245,462 - $279,042
9,125 Added 1153.6%
9,916 $280,000
Q3 2022

Nov 10, 2022

SELL
$29.42 - $42.25 $17,710 - $25,434
-602 Reduced 43.22%
791 $24,000
Q2 2022

Aug 10, 2022

SELL
$30.15 - $45.79 $37,054 - $56,275
-1,229 Reduced 46.87%
1,393 $47,000
Q1 2022

May 16, 2022

BUY
$36.01 - $53.14 $6,265 - $9,246
174 Added 7.11%
2,622 $117,000
Q4 2021

Feb 14, 2022

BUY
$32.35 - $48.27 $79,192 - $118,164
2,448 New
2,448 $113,000
Q3 2021

Nov 15, 2021

SELL
$29.5 - $37.21 $88 - $111
-3 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$24.04 - $29.79 $40,315 - $49,957
-1,677 Reduced 99.82%
3 $0
Q1 2021

May 12, 2021

BUY
$22.3 - $26.02 $11,952 - $13,946
536 Added 46.85%
1,680 $43,000
Q4 2020

Feb 11, 2021

SELL
$20.62 - $25.0 $4,371 - $5,300
-212 Reduced 15.63%
1,144 $26,000
Q3 2020

Nov 12, 2020

SELL
$21.0 - $24.61 $24,864 - $29,138
-1,184 Reduced 46.61%
1,356 $29,000
Q2 2020

Jul 31, 2020

SELL
$18.68 - $24.35 $39,302 - $51,232
-2,104 Reduced 45.31%
2,540 $59,000
Q1 2020

May 01, 2020

SELL
$16.08 - $27.67 $26,371 - $45,378
-1,640 Reduced 26.1%
4,644 $99,000
Q4 2019

Feb 14, 2020

BUY
$21.11 - $25.92 $30,123 - $36,987
1,427 Added 29.38%
6,284 $147,000
Q3 2019

Nov 14, 2019

BUY
$18.06 - $24.1 $10,944 - $14,604
606 Added 14.26%
4,857 $102,000
Q2 2019

Aug 14, 2019

BUY
$19.6 - $29.31 $53,606 - $80,162
2,735 Added 180.41%
4,251 $87,000
Q1 2019

May 14, 2019

SELL
$23.58 - $28.43 $919 - $1,108
-39 Reduced 2.51%
1,516 $43,000
Q4 2018

Feb 14, 2019

SELL
$20.63 - $34.04 $6,457 - $10,654
-313 Reduced 16.76%
1,555 $38,000
Q3 2018

Nov 14, 2018

SELL
$20.6 - $37.15 $3,234 - $5,832
-157 Reduced 7.75%
1,868 $69,000
Q2 2018

Aug 14, 2018

BUY
$14.15 - $20.75 $3,622 - $5,312
256 Added 14.47%
2,025 $42,000
Q1 2018

May 15, 2018

BUY
$13.0 - $15.8 $364 - $442
28 Added 1.61%
1,769 $25,000
Q4 2017

Feb 14, 2018

BUY
$10.0 - $15.7 $17,410 - $27,333
1,741 New
1,741 $26,000
Q3 2017

Nov 14, 2017

SELL
$9.4 - $10.55 $38,822 - $43,571
-4,130 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
2,564 Added 163.73%
4,130 $35,000
Q1 2017

Nov 14, 2017

BUY
N/A
1,566
1,566 $14,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $687M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.